ADC Therapeutics (ADCT) Non Operating Interest Expenses (2020 - 2026)
ADC Therapeutics (ADCT) reported Non Operating Interest Expenses of $13.51 million for Q2 2026, up 3.9% from $13 million a year earlier and up 9.4% from the prior quarter.
Powered by 
Analysis
ADC Therapeutics (ADCT) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, ADC Therapeutics' Non Operating Interest Expenses came in at $52.25 million, up 2.4% year-over-year.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Interest Expenses in data going back to Q1 2020.
- Year over year, Non Operating Interest Expenses gained in five of the last six quarters, with growth averaging 1.6%.
- The high point for year-over-year Non Operating Interest Expenses in five years was Q1 2022 (growth of 360.9%); the low point was Q1 2025 (a decline of 2.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | ADC Therapeutics | 152.93 Mn | -793.27 Mn | 16.90 Mn | 13.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.51 Mn |
| Mar 31, 2026 | 12.35 Mn |
| Sep 30, 2025 | 13.39 Mn |
| Jun 30, 2025 | 13.00 Mn |
| Mar 31, 2025 | 12.23 Mn |
| Sep 30, 2024 | 13.12 Mn |
| Jun 30, 2024 | 12.68 Mn |
| Mar 31, 2024 | 12.50 Mn |
| Sep 30, 2023 | 12.82 Mn |
| Jun 30, 2023 | 10.31 Mn |
| Mar 31, 2023 | 10.42 Mn |
| Sep 30, 2022 | 11.36 Mn |
| Jun 30, 2022 | 8.80 Mn |
| Mar 31, 2022 | 9.22 Mn |
| Sep 30, 2021 | 4.27 Mn |
| Jun 30, 2021 | 2.56 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Sep 30, 2020 | 1.94 Mn |
| Jun 30, 2020 | 897,000.00 |
| Mar 31, 2020 | 42,000.00 |
API Access
ADC Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ADCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ADCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ADCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();